Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas.
Sameer Farouk SaitStephen W GilheeneyTejus A BaleSofia S HaqueMarc J DinkinStephanie VitolanoMarc K RosenblumKatarzyna IbanezDaniel E PrinceKrisoula H SpatzIra J DunkelMatthias A KarajannisPublished in: JCO precision oncology (2021)
Keyphrases